Top compounds associated with response to SELT


Feature Type Standardized
Nominal ANOVA
mRNA clofarabine CTRPv2 pan-cancer AAC -0.093 0.001
mRNA serdemetan FIMM pan-cancer AAC -0.48 0.001
mRNA Mitomycin-C CTRPv2 pan-cancer AAC -0.11 0.001
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.001
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.098 0.001
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC -0.096 0.002
mRNA GSK1070916 GDSC1000 pan-cancer AAC -0.096 0.002
mRNA Rapamycin GDSC1000 pan-cancer AAC 0.15 0.002
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.097 0.002
Download CSV